Prolonged rapamycin treatment inhibits mTORC2 and Akt/PKB assembly - Review of the evidence

Evidence from cell and animal studies shows prolonged rapamycin can inhibit mTORC2 assembly and Akt signaling. Clinical relevance remains uncertain.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-19
DOI
https://doi.org/10.5281/zenodo.24366638
Primary Topic
PI3K/AKT/mTOR signaling in cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prolonged rapamycin treatment inhibits mTORC2 and Akt/PKB assembly - Review of the evidence

Deborah Iodice
Zenodo (CERN European Organization for Nuclear Research)
PI3K/AKT/mTOR signaling in cancer
article

Prolonged rapamycin treatment inhibits mTORC2 and Akt/PKB assembly - Review of the evidence

Deborah Iodice
article en

Abstract

Evidence from cell and animal studies shows prolonged rapamycin can inhibit mTORC2 assembly and Akt signaling. Clinical relevance remains uncertain.

Zenodo (CERN European Organization for Nuclear Research)
PI3K/AKT/mTOR signaling in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon